 |
Journal articles
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
Irene Pachón-Angona
Bernard Refouvelet
Rudolf Andrýs
Helène Martin
Vincent Luzet
Isabel Iriepa
Ignacio Moraleda
Daniel Diez-Iriepa
María-Jesús Oset-Gasque
José Marco-Contelles
Kamil Musilek
Lhassane Ismaili
1
María-Jesús Oset-Gasque
Author
José Marco-Contelles
Author
Kamil Musilek
Author ORCID : https://orcid.org/0000-0002-7504-4062
Lhassane Ismaili 1
Author IdHAL : lhassane-ismaili ORCID : https://orcid.org/0000-0002-6013-3150
Document type :
Journal articles
Complete list of metadata
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03654661
Contributor : Lhassane Ismaili Connect in order to contact the contributor
Submitted on : Thursday, April 28, 2022 - 5:20:03 PM
Last modification on : Friday, April 29, 2022 - 3:08:35 AM
Contributor : Lhassane Ismaili Connect in order to contact the contributor
Submitted on : Thursday, April 28, 2022 - 5:20:03 PM
Last modification on : Friday, April 29, 2022 - 3:08:35 AM
Links full text
Identifiers
- HAL Id : hal-03654661, version 1
- DOI : 10.1080/14756366.2018.1545766
- PUBMEDCENTRAL : PMC6366423
Collections
Citation
Irene Pachón-Angona, Bernard Refouvelet, Rudolf Andrýs, Helène Martin, Vincent Luzet, et al.. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy. Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2019, 34 (1), pp.479-489. ⟨10.1080/14756366.2018.1545766⟩. ⟨hal-03654661⟩
Metrics
Record views